ASCO Lung Cancer Roundtable – NSCLC – Enhertu and the Potential for Treatment of HER2 Positive NSCLC

We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with Helena A. Yu, MD, medical oncologist with Memorial Sloan Kettering specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.

Drs. West, Yu and Spigel discuss trial updates in non small cell lung cancer. For this video, the topic of discussion is Enhertu and the potential for treatment of HER2 positive NSCLC.

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.